Immunomodulatory drugs Revlimid® (lenalidomide) and CC-4047 induce apoptosis of both hematological and solid tumor cells through NK cell activation

Overview of attention for article published in Cancer Immunology, Immunotherapy, April 2008

Altmetric Badge

Mentioned by

patent: 10 patents

Citations

dimensions_citation: 150 Dimensions

Readers on

mendeley: 67 Mendeley

Summary Patents Dimensions citations

So far, Altmetric has seen 10 patents that reference this research output.

Methods for treating multiple myeloma and the use of companion biomarkers for 4-(4-(4-(((2…

Grant US-11726080-B2

United States of America

Methods for treating multiple myeloma and the use of companion biomarkers for 4-(4-(4-(((2…

Grant US-10969381-B2

United States of America

Forms and compositions of an ERK inhibitor

Grant US-10202364-B2

United States of America

Forms and compositions of an ERK inhibitor

Grant US-10005760-B2

United States of America

ERK inhibitors and uses thereof

Grant US-9980964-B2

United States of America

ERK inhibitors and uses thereof

Grant US-9796700-B2

United States of America

ERK inhibitors and uses thereof

Grant US-9561228-B2

United States of America

ERK inhibitors and uses thereof

Grant US-9504686-B2

United States of America

Methods of treating a disease or disorder associated with Bruton'S Tyrosine Kinase

Grant US-9492471-B2

United States of America

ERK inhibitors and uses thereof

Grant US-9145387-B2

United States of America